Author(s):
Punita R Maurya, Yadunath M Joshi, Vilasrao J Kadam.
Email(s):
Email ID Not Available
DOI:
Not Available
Address:
Punita R. Maurya*, Yadunath M. Joshi, Vilasrao J. Kadam.
Department of Pharmacology, BharatiVidyapeeth’s College of Pharmacy, Sector-8, C.B.D. Belapur, NaviMumbai-400614, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 5,
Issue - 4,
Year - 2013
ABSTRACT:
Bronchial asthma is chronic inflammatory disorder of the respiratory tract, characterised by increased airway hyper responsiveness to provocative exposures and episodic airflow obstruction. It is an increasing global health burden, especially in the Western world. As we learn more about the cause, pathophysiology, phenotypes and genetics of asthma; treatments will become available to ensure adequate asthma control; even may help in development and implementation of an optimal strategy for its management and prevention. This review article summarizes current pharmacological approaches for the management of asthma, including an update on the definition, types, cause, appropriate diagnostic evaluation, and pathogenesis of bronchial asthma.
Cite this article:
Punita R Maurya, Yadunath M Joshi, Vilasrao J Kadam.
A Review on Bronchial asthma. Research J. Pharmacology and Pharmacodynamics. 2013; 5(4). 257-265.
Cite(Electronic):
Punita R Maurya, Yadunath M Joshi, Vilasrao J Kadam.
A Review on Bronchial asthma. Research J. Pharmacology and Pharmacodynamics. 2013; 5(4). 257-265. Available on: https://rjppd.org/AbstractView.aspx?PID=2013-5-4-25